Vaccines based on recombinant attenuated bacteria represent a potentially safe and effective immunization strategy. A carrier system was developed to analyze in vitro whether foreign T cell epitopes, inserted in the outer membrane protein PhoE of Escherichia coli and expressed by recombinant bacteria, are efficiently processed and presented via human leukocyte antigen (HLA) class I and I1 molecules by bacterial infected human macrophages. A well-defined HLA-B27-restricted cytotoxic T cell (CTL) epitope and an HLA-DR53 restricted T helper (Th) epitope of the fusion protein of measles virus were genetically inserted in a surface-exposed region of PhoE, and the chimeric proteins were expressed in E. coli and Salmonella typhimurium. Macrophages infected with both recombinant bacteria presented the Th epitope to the specific CD4+ T cell clone, but failed to present the CTL epitope to the specific CD8+ Tcell clone. Presentation of the Th epitope by the infected macrophages was inhibited by cytochalasin D, indicating that phagocytic processing of intact bacteria within infected macrophages was essential for antigen presentation via HLA class 11. Presentation of theTh epitope to the CD4+ T cell clone by infected macrophages was blocked by brefeldin A and cycloheximide, indicating the requirement of nascent HLA class I1 molecules for presentation. The efficiency of macrophages to process and present the inserted T h epitope was similar for both the recombinant E. coli and S. typhimurium strains.
Introduction
Avirulent Salmonella strains have been generated to be used as live Salmonella vaccine [l] . These attenuated Salmonella strains and several E. coli strains have also been evaluated for their ability to present heterologous antigens to the immune system [2-81. In such recombinant strains bacterial carrier proteins are frequently employed to present inserted antigenic determinants in the appropriate immunogenic form to the immune system of the host.
While the T cell-mediated immune response to intracellularly residing bacteria was initially thought to be solely mediated by CD4+ Tcells, the additional role of CD8+ Tcells is now generally accepted [9] . The role of CD8+ T cell-mediated immunity against intracellular bacteria has first been shown for Listeria monocytogenes [lo, 111. Since L. monocytogenes enters the cytosol after lysis of the phagosome, the peptides presented by MHC class I mole- [I 135611 * This study was supported by Het Nationaal Reumafonds of the Netherlands and the project management group on Immunogenetics of the European Concerted Action on Immunopathogenesis and Immunotherapy of Chronic Arthritis.
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cules were originally thought to be generated from degradation of bacterial proteins in the cytosol [12] . However, it has recently been shown that listerial antigens can also be introduced into the MHC class I pathway independent of the egression of L. monocytogenes from the phagosome [13] . The ability of Mycobacterium [14, 151 and Salmonella [16, 17] , which reside intracellularly within phagosomes, to elicit specific CD8+ T cell responses in vivo, underlines the possibility that antigens located within the endosomal compartment can be presented by MHC class I molecules. Moreover, oral immunization of mice with attenuated S. typhimurium strains expressing heterologous antigens was shown to induce a specific CD8+ T cell response [ 181, which in some cases conferred protective immunity to the specific pathogen [8] . The processing pathway for presentation of T cell epitopes expressed by the phagosomally residing E. coli and S. typhimurium has recently been studied in vitro using peritoneal mouse macrophages [19, 201. It was observed that theT cell epitopes were efficiently processed and presented via MHC class I and 11. In contrast, other groups have not been able to show class I presentation in vitro of recombinant bacterial antigens by cells infected with S. typhimurium [7, 211. We have previously shown that both B-and T-cell epitopes can be inserted within the surface-exposed regions of the E. coli outer membrane protein PhoE without disturbing the biogenesis of the protein (for a review see [22] ). Each monomer of this trimeric protein traverses the outer membrane 16 times in an antiparallel P-sheet structure, thereby exposing eight regions at the cell surface [23] . In the rat system, using purified chimeric PhoE trimers, CD4+ T cell responses specific to an inserted epitope have been observed in vitro and in vivo [24, 251. In the present study, an in vitro model system was developed to analyze the applicability of the PhoE carrier protein to permit presentation of inserted T cell epitopes via HLA class 1 and I1 by human macrophages infected with recombinant bacteria. Well-defined CTL and Th epitopes of measles virus were employed and the efficacy of recombinant E. coli and an attenuated S. typhimurium strain to present the epitopes were compared.
Materials and methods

Bacterial strains and growth conditions
The E. coli K-12 strain CE1224 produces no pore proteins due to mutations in the phoE and ompR genes [26] . The S. typhimurium strain SL3261, obtained from B. A. D. Stocker (Stanford University, CA), is unable to synthesize aromatic amino acids and is therefore avirulent, but it has not lost its ability to enter (non-) phagocytic cells [1] . Bacteria were grown overnight at 37 "C under aeration in Luria-Bertani (LB) medium, supplemented where necessary with ampicillin (50 pg/ml). Bacteria were inactivated by heat treatment for 15 min at 100°C.
MVF peptides and T cell clones
Synthetic peptides corresponding to the T cell epitopes of MVF, peptide 437-447 (CTL epitope) and peptide 453-464 (Th epitope), were prepared by solid-phase synthesis [27] . The isolation, maintenance and properties of the MVFspecific CD4+ (JP-F94) and CD8+ (WH-F40) T cell clones used have been described [27] . The T cell clones JP-F94 and WH-F40 recognize the epitopes PPISLERLDVGT (amino acid residues 453-464) and SRRYPDAVYLH (residues 437-447) in association with HLA-DR53 and HLA-B27, respectively [27] .
Construction and characterization of the chimeric PhoE proteins
Chimeric proteins consisting of the E. coli PhoE protein with insertions of the Th or CTL epitope of MVF were genetically constructed by the strategy described previously [24] . Restriction enzymes and other DNA modifying enzymes were purchased from Pharmacia (Uppsala, Sweden). The expression vector pMR08 contains the phoE gene with a Bam HI linker insertion [28] . PMR08 was digested with Bam HI and ligated withT4 DNA ligase to the linkers encoding the Tcell epitopes (Fig. 1) . Insertion in the wrong orientation would result in the introduction of a stop codon in the reading frame of PhoE. Correct insertion of the linkers was verified by sequencing using the T7 DNA polymerase sequencing kit (Pharmacia, Uppsala, Sweden). The plasmids containing the CTL-and Th epitope were designated pRM30 and pRM31, respectively. Plasmid pRMOl contains the wild-type phoE gene behind the lac promoter [29] . The recombinant phoE genes were inserted behind the lac promoter by digestion of pRM30, pRM31 and pRMO1 with Mlul and BglII and ligation of the appropriate DNA fragments with T4 DNA ligase. The resulting plasmids encoding PhoE with the inserted CTL and Th epitopes were designated pRM40 and pRM41, respectively.
Human macrophages
Tissue culture reagents were obtained from Gibco Laboratories (Grand Island, NY). Cells were cultured in complete medium: RPMI 1640 supplemented with 10% heat-inactivated fetal calf serum (FCS-c), penicillin (100 IU/ml) and streptomycin (100 pg/ml). PBMC were isolated from heparinized blood samples of healthy €€LA-matched blood donors by Ficoll-Paque density gradient centrifugation (Pharmacia, Uppsala, Sweden). PBMC were depleted of monocytes by differential adherence to plastic petridishes. The nonadherent cells were removed with pre-warmed (37 "C) complete medium and the adherent cells were harvested with a rubber policeman and ice-cold phosphatebuffered saline (PBS) [30] . The adherent cells, -95% monocytes, were seeded at a concentration of 2 x lo4 per well (100 pl) in 96-well round-bottom microtiter plates. To obtain macrophages, monocytes were cultured for 14 days at 37°C in a C02 incubator. During this period, the monocytes had acquired a macrophage morphology and function [31] .
T cell proliferation assays
HLA-matched macrophages were used as antigen-presenting cells. Macrophages were incubated in RF'Ml 1640 medium containing 10% heat-inactivated pooled human serum (HS-c) with various amounts of peptide, viable or heat-killed recombinant bacteria for 2 h at 37 "C in a C02 incubator. Following incubation, the macrophages were extensively washed with RPMI 1640 and incubated for 1 h at 37 "C in a C02 incubator in medium containing 200 pg/ml gentamycin to kill extracellular bacteria [32] . The medium was replaced by medium containing 20 pg/ml gentamycin and the cells were irradiated (300 rad). The Tcell clones JP-F94 (2 x lo4 cells/well) or WH-F40 (5 x lo4 cells/well)
were added to the macrophages and cultured for 3 days at 37°C in a C02 incubator. The cells were labeled with [3H] thymidine during the last 18 h of culturing, harvested, and the incorporated radioactivity was counted in a flat-bed @-scintillation counter.
Treatment of macrophages with drugs
To determine the kinetics and requirements for antigen processing, the macrophages were fixed for 30 s with 0.05% glutaraldehyde [21] , either before or at different time points after incubation with the antigen preparations. The reaction was stopped by adding L-glycine at a final concentration of 200mM, and the macrophages were washed several times with RPMI 1640 containing 20 mM L-glycine. Subsequently, RPMI 1640 supplemented with 10% HS-c and 20 pg/ml gentamycin was added and the fixed macrophages were used as stimulator cells in proliferation assays. If appropriate, the macrophages were pretreated for 30 min with brefeldin A (1 pg/ml), cycloheximide (10 pg/ml) or cytochalasin D (5 pg/ml) (Sigma, St. Louis, MO). In the presence of the same concentrations of inhibitors, macrophages were incubated with the antigen preparations for 2 h, washed, and reincubated for 3 h as described in Sect. 2.5. The macrophages were then washed extensively and fixed with glutaraldehyde.
Results
Construction of plasmids and characterization of chimeric PhoE proteins
To study the applicability of the PhoE protein to permit the presentation of inserted epitopes via MHC class I and I1 in human macrophages, two chimeric PhoE proteins were constructed. Synthetic oligonucleotide linkers coding for the HLA-B27-restricted epitope 437-447 and for the HLA-DR53 restricted epitope 453-464 of MVF were in the DNA encoding the fourth cell-surface exposed region of the PhoE protein (Fig. 1) . The recombinant plasmids encoding the chimeric PhoE proteins with either the CTL or the Th epitope under control of the lac promoter, were designated pRM40 and pRM41, and the chimeric PhoE proteins are referred to as PhoE-CTL4 and PhoE-TH4, respectively. These plasmids were used to transform the E. coli K-12 strain CE1224 and the attenuated S. typhimurium strain SL3261. Analysis of cell envelopes and peptidoglycan-protein complexes by SDS-PAGE and Western immunoblotting revealed that the chimeric PhoE proteins were constitutively expressed at high levels and assembled into trimers (data not shown). This indicates that the chimeric proteins were correctly assembled in the outer membrane. 
T cell recognition of human macrophages infected with recombinant bacteria
To determine whether the inserted MVF Th epitope can correctly be presented via HLA class 11, human macrophages were infected with the recombinant strains expressing PhoE-TH4. The infected macrophages were able to process and present the inserted Th epitope to the specific CD4+ Tcell clone JP-F94 (Fig. 2) . For both bacterial strains, the optimal Tcell response was observed at a multiplicity of infection (MOI) of 10. As expected, the T cell clone also responded to macrophages pulsed with the corresponding synthetic MVF peptide, but not to macrophages infected with the recombinant bacterial strains expressing PhoE-CTL4 (Fig. 2) . This indicates that the observed T cell response is not attributable to nonspecific mitogenic effects of bacterial products.
To determine whether the inserted CTL epitope can correctly be presented via HLA class I, macrophages were infected with recombinant bacteria expressing PhoE- CTL4. In contrast to macrophages pulsed with the corresponding synthetic MVF (437-447) peptide, the infected macrophages were not recognized by the T cell clone WH-F40 (data not shown).The possibility that the bacterial infection disrupted the expression of HLA-B27 or accessory molecules required for proliferation of the T cell clone, was excluded by the observation that the infected macrophages were still able to present the synthetic MVF (437-447) peptide (data not shown).
Kinetics of antigen processing in human macrophages
To determine the kinetics of antigen processing, macrophages were fixed with glutaraldehyde to stop processing before or at several time points after the addition of either peptide, viable or heat-killed bacteria expressing PhoE-TH4. Prefixation of the macrophages abolished presentation of the Th epitope by macrophages incubated with either viable or heat-killed recombinant bacteria, but not by those incubated with the MVF peptide (453-464) (Fig. 3) . This indicates that processing of PhoE-TH4 by viable macrophages is required for presentation of the Th epitope. Optimal presentation of the Tcell epitope was observed within 1-3 h und 3-5 h for macrophages incubated with heat-killed or viable bacteria, respectively. Maximal T cell recognition of macrophages pulsed with peptide was observed after 1 h of incubation (Fig. 3) . No differences were observed between the bacterial strains used.
Inhibition of presentation of the MVF T h epitope by cytochalasin D, brefeldin A and cycloheximide
To determine whether the presentation of theTh epitope by infected macrophages was actually due to phagocytic processing of intact bacteria, rather than to processing of PhoE-TH4 released from lysed bacteria, cytochalasin D was used. Cytochalasin D inhibits the phagocytic capability of cells [33] . Treatment of macrophages with cytochalasin D before incubation with the viable recombinant bacteria of both strains expressing PhoE-TH4 abolished the proliferative response of the Tcell clone JP-F94 (Fig. 4) . On the other hand, cytochalasin D-treated macrophages showed optimal T cell stimulation upon incubation with peptide or heat-killed bacteria.
Pretreatment of macrophages with brefeldin A or cycloheximide inhibited the presentation of the Th epitope after incubation with either viable or heat-killed recombinant bacteria (Fig. 4) . No differences were observed between the bacterial strains. In contrast, drug-treated macrophages were still able to present the MVF (453-464) peptide.
We have previously shown in the rat system that purified chimeric PhoE proteins containing class 11-restricted T cell epitopes are, both in vitro and in vivo, presented to CD4+ T cells [24, 25] .We have now demonstrated that aTh epitope expressed as chimeric PhoE protein in E. coli and attenuated S. typhimurium is efficiently processed and presented to human CD4+ T cells by infected human macrophages.
In contrast to E. coli K-12, S. typhimurium survives within macrophages by inhibiting the fusion of phagosome and lysosome [34] . Since phagosomefiysosome fusion is required for processing and presentation of internalized bacterial antigens by class I1 molecules [35] , we compared the antigen processing kinetics of PhoE-TH4 in macrophages infected with either the E. coli strain CE1224.pRM41 or the S. typhimurium strain SL3261.pRM41. Surprisingly, maximal presentation of the inserted epitope was observed within a similar time period for both bacterial strains, i.e. 3-5 h after infection. Therefore, the survival of both strains within human macrophages was analyzed. The number of viable intracellular E. coli (CE1224.pRM41) bacteria declined rapidly upon internalization. S. typhimurium (SL3261.pRM41), entered the macrophages approximately tenfold more efficiently than the E. coli strain and multiplied intracellularly within the first 3 h of infection, but was killed effectively upon further incubation (data not shown). It should be noted that these observations are only indicative for the survival of the total population of intracellular bacteria and not for individual bacteria. It has been observed that a significant amount of S. typhimurium-containing phagosomes do fuse with lysosomes [34] .The higher numbers of S. typhimurium internalized, and the amount of S. typhimurium containing phagolysosomes formed, is possibly sufficient to generate the limited amount of MHC/peptide-complexes required for T cell activation, resulting in similar antigen processing kinetics as for E. coli. When heat-killed bacteria were used, maximal T cell activation was already observed between 1-3 h after incubation. Probably, the PhoE-TH4 protein within the heat-killed bacterial preparations is directly accessible for antigen processing after internalization, whereas internalized viable bacteria first have to be degraded following phagosome/lysosome fusion. No evidence was found for recognition of human macrophages, infected with recombinant bacteria expressing PhoE-CTU, by the specific CD8+ Tcell clone. This inability of bacteria-infected macrophages to confer presentation of antigenic determinants via class I is in contrast to other reports 119,201. In those studies, activated murine peritoneal macrophages were used as antigen-presenting cells, and a class I-restricted T cell epitope was expressed as chimeric protein in E. coli or S. typhirnuriurn [19, 201 . In addition to the soluble bacterial proteins Crl and MalE, the outer membrane protein LamB was used as carrier protein [20] . Since LamB and PhoE are structurally similar 1381, and the amounts of chimeric PhoE and LamB proteins expressed at the bacterial cell surface were both very high, these factors do probably not account for the discrepancy observed. One difference between the studies, which might be of importance is the antigen-presenting cell used. It has recently been shown that murine macrophages can process and present exogenous antigens, either in soluble form or bound to beads, via class I molecules [39] . Since in that study [39] , and in those described by others [19, 20] , in vivo matured macrophages were used as antigen-presenting cell, we hypothesize that the human macrophages used in the present study, which had differentiated in vitru from monocyte to macrophage, have not acquired the potential to process and/or present the CTL epitope upon infection with the recombinant bacteria. The inability of Chinese hamster ovary (CHO) cells to present a CTL epitope upon infection with recombinant $. typhirnuriurn [7] underlines the proposed cell type specificity. Alternatively, the peptide corresponding to the CTL epitope might not be generated because of negative effects of flanking residues of the carrier protein [25, 401 . Future experiments using in vivo matured human macrophages, and insertion of the CTL epitope including its native flanking residues into PhoE, will be directed to discriminate between these possibilities.
